Skip to main content

Connect with a Patient Ambassador

Thank you for your interest in connecting with a Patient Ambassador.

An Enterra Medical Patient Liaison will be in contact with you.

Introduction to Enterra Therapy

Watch a 3 minute video explaining gastroparesis and Enterra Therapy

Understand the technology behind Enterra Therapy

Learn more about gastric electrical stimulation (GES).

Find a provider

Search for Enterra Therapy providers.

MKT-D-0003, Rev S


Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.


Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?